Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
This study is currently recruiting participants.
Verified February 2013 by San Antonio Military Medical Center
Study NCT01570036   Information provided by San Antonio Military Medical Center

First Received on March 25, 2012.   Last Updated on February 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Herceptin
NeuVax vaccine
GM-CSF
Additional drug interventions recognized in this trial
Trastuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
COL George Peoples, MD, FACS
Genentech
Galena Biopharma, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services